CAS number: 71-58-9

General information about the Medroxyprogesterone acetate active pharmaceutical ingredient

Medroxyprogesterone acetate as active pharmaceutical ingredient (API) is a steroidal progestin, a synthetic variant of the human hormone progesterone,commonly abbreviated as MPA. it is used for contraception, menopausal hormone therapy, abnormal bleeding and endometriosis. Medroxyprogesterone acetate API Medroxyprogesterone works in the same way as natural progesterone,changing the proliferative phase to the secretory phase of the endometrium. Medroxyprogesterone acetate comes in different forms, injectable, oral and tablets. High doses Medroxyprogesterone acetate are used to treat some types of cancer. Medroxyprogesterone acetate It also comes mixed with another hormone called estrogen. This is used as a type of hormone replacement therapy , for menopause symptoms.

Axplora manufactures Medroxyprogesterone acetate API

Medroxyprogesterone acetate API is manufactured in cGMP by Axplora via chemical synthesis from early stage starting material. Medroxyprogesterone acetate API is produced by Farmabios, our EUGMP, USFDA and PMDA approved manufacturing site with legal seat in Gropello Cairoli, Italy. Farmabios’ expertise is to make and handle with steroids, niche hormones, and highly potent active pharmaceutical ingredient (HPAPI), including cytotoxic drugs. Medroxyprogesterone acetate API is commercially available as micronized grade specifically designed around various formulation requirements. Medroxyprogesterone acetate API is also available as sterile product (hyperlink for MAP sterile). Tailor-made packaging solutions are available upon request. Feel free to contact us if you need any additional information about Medroxyprogesterone acetate API.
  • Therapeutic area Contraceptive
  • Monograph PH.EUR.
  • Available grade Micronized
  • Regulatory documentation US DMF
    JP DMF
  • Produced in GRO